Call for Abstracts
After the record-breaking success of EUCROF26 in Amsterdam, we are excited to invite abstract submissions for oral presentations at EUCROF27, taking place 14-16 February 2027 in Prague, Czechia.
Once a biennial event, the EUCROF Conference is now a key annual event in the clinical research calendar, bringing together professionals, experts, and patients from across Europe and beyond. The 2027 programme will feature keynote sessions, panels, and two breakout streams: one dedicated to clinical operations, the other to Regulatory topics.
We welcome abstracts that offer insights, experiences, or innovations related to clinical research. Submissions should be clear, relevant, and aimed at sharing practical value with the wider research community.
Submission Deadline: 29 June 2026
Suggested Operational Topics
- Overcoming operational differences between European Countries
- Selecting countries for multi-national clinical trials
- Feasibility (incl process, selecting sites and countries, use of technologies)
- Using European patient groups for the design and delivery of clinical trials
- Risk based management of trials in Europe
- Risk assessment for delivering clinical trials in Europe
- Delivering cross border trials (incl rare diseases)
- Europe as part of a global trial
- Resource availability and development in Europe (eg CRAs, PMs)
- The UK as part of Europe but not the EU – impact on trial delivery
- Decentralised trials: progress, enablers and challenges
- Patient involvement across the clinical trial lifecycle
- Trials in rare diseases and paediatric populations: challenges and solutions
- Clinical trials involving medical devices and in vitro diagnostics
Suggested Regulatory Topics
- EU Clinical Trials Regulation – experiences from different stakeholders
- Biotech Act and future evolution of the EU Clinical Trials Regulation and Medical Device Regulation
- Regulatory considerations for new tools and methodologies in clinical trials
- Designing fit-for-purpose clinical trials and the role of scientific advice
- Impact of new EU Pharmaceutical Legislation on clinical trials
- Accelerating Clinical Trials in the EU (ACT EU): progress and impact
- Fast-track initiatives in the EU and beyond: experiences and recommendations
- Regulatory and ethics review: centralisation versus decentralisation
- Expediting study start-up and recruitment through regulatory approaches
- The role of clinical research intelligence in trial planning and delivery
- Early experiences with the new UK Clinical Trials Regulations
- Breakthrough Medical Devices and Innovative Technologies in Europe
Submit your Abstract Now
Register for EUCROF27 Conference Updates
Keep up with announcements for EUCROF27 Conference.